InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by MERRIFIELD C ANN, Director. Insider active across 2 companies, notably Lyra Therapeutics, Inc.. Aggregated, 8 reports have been published. Total volume traded: €88k. The latest transaction was filed on 10 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
€19,0224,000 shares@ €4.75551.53% mcap21.6% of flow
Common Stock
SEC:0000899243-22-022154:0·
Ideal exit: 7 Mar 2023 (T+270)
€16,2293,500 shares@ €4.6371.31% mcap18.5% of flow
Common Stock
SEC:0000899243-22-018435:0·
Ideal exit: 7 Feb 2023 (T+270)
€142,06019,000 shares@ €7.4769100.0% of flow
Common Stock
SEC:0001209191-21-065720·
€142,06019,000 shares@ €7.476950.0% of flow
Common Stock
SEC:0001209191-21-065720:0·
04,500 shares0
Common Stock
SEC:0001209191-21-043555·
04,500 shares0
Common Stock
SEC:0001209191-21-043555:0·
€26,3523,500 shares@ €7.5292100.0% of flow
Common Stock
SEC:0000899243-21-025288·
Ideal exit: 14 Mar 2022 (T+270)
€26,3523,500 shares@ €7.52922.12% mcap30.0% of flow
Common Stock
SEC:0000899243-21-025288:0·
Ideal exit: 14 Mar 2022 (T+270)
8 of 8 declarations
About MERRIFIELD C ANN
C. Ann Merrifield is a Director at Lyra Therapeutics, Inc. and Flexion Therapeutics Inc. She plays an important role in the governance and strategy of these companies. Her expertise in biotechnology contributes to guiding strategic decisions and supporting innovation.
